J Mov Disord.
2024 Apr;17(2):208-212. 10.14802/jmd.23172.
Accessibility of Device-Aided Therapies for Persons With Parkinson’s Disease in Poland
- Affiliations
-
- 1Department of Neurology, 5th Regional Hospital, Sosnowiec, Poland
- 2Radboud University Medical Centre; Donders institute for Brain, Cognition and Behaviour; Department of Neurology; Centre of Expertise for Parkinson & Movement Disorders; Nijmegen, The Netherlands
- 3Research Centre for Public Policy and Regulatory Governance, Faculty of Law and Administration, University of Silesia in Katowice, Katowice, Poland
- 4King’s College London, Institute of Psychiatry, Psychology & Neuroscience, Department of Basic and Clinical Neuroscience, London, UK
- 5Parkinson’s Foundation Center of Excellence, King’s College Hospital, Denmark Hill, London, UK
- 6King’s College London, Institute of Psychiatry, Psychology & Neuroscience, Department of Neuroimaging, London, UK
- KMID: 2554695
- DOI: http://doi.org/10.14802/jmd.23172
Abstract
Objective
Access to care for people with Parkinson’s disease (PD), particularly to device-aided therapies (DAT), is not equally distributed. The objective was to analyze accessibility to DAT (deep brain stimulation, intraduodenal levodopa pump therapy, and apomorphine pump therapy) in Poland.
Methods
We analyzed the distribution of DAT use in Poland by determining the number of persons with PD receiving one of the three DATs during 2015–2021.
Results
In 2021, the number of persons receiving DAT in Poland was 0.56% of the total PD population, increasing from 0.21% in 2015. Overall, deep brain stimulation was the preferred DAT in Poland, but strong regional differences in the use of the other DATs were observed. Accessibility to DAT was negatively associated with average annual income (p < 0.001).
Conclusion
Access to DAT for persons with PD in Poland is still limited, and strong regional differences in accessibility were observed, although its general increase over the last decade is encouraging.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Neuroprotective Therapy in Parkinson's Disease: Current Status and New Directions from Experimental and Genetic Clues
- A Case of Poland Syndrome with Diabetic Ketoacidosis
- Pathogenetic factors in Parkinson disease and novel experimental therapies
- The History of Parkinson's Disease and Famous Patients
- A Case of Poland Syndrome
